The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Novo's blockbuster diabetes drug Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients ...

Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes.

A team of environmental biologists at the Chinese Research Academy of Environmental Sciences, working with one colleague from Duke University, and another from National University of Singapore, has ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of ...

Microbe-derived indoles modulate anxiety and neuronal excitability in the amygdala of germ-free (GF) male mice. These ...